In our previous work, we employed to block Pannexin-1 channel in mice a drug Probenecid that is employed in clinic to increase uric acid excretion in gout patients that in addition possess some additional effect as Pannexin-1 channel inhibitor, and we noticed impaired G-CSF-mediated mobilization [11]. This evidence concerns the gene CSF3 and gout.